Additionally, the results revealed that RBP7 mRNA expression levels were significantly lower in most cancer samples than their corresponding normal samples, including breast invasive carcinoma (BRCA), uterine corpus endometrial carcinoma (UCEC), and lung adenocarcinoma (LUAD). The gene discussed is RBP7; the disease is cancer.